GSK To Target India's Lower-income Sector By Cutting Prices
This article was originally published in PharmAsia News
Executive Summary
Lower-income Indians should see a lowering of GlaxoSmithKline retail prices as the U.K.-based drug maker seeks to position itself for that segment of India's market, the GSK head said